The role of the proline rich homeodomain in the regulation of proliferation, survival and migration of breast cells
Explore this paper's citation graph
Summary
The role of PRH can differ dramatically between breast cell types and between ex vivo and in vivo conditions, providing an explanation for the finding that PRH expression is associated with increased overall survival in breast cancer patients.
- Type
- dissertation
- Published
- 2014-07-01
- Cited by
- 1
- References
- 251
- Access
- Open access
- OpenAlex
- https://openalex.org/W66760477
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:81061144
Keywords
Gene knockdown, Small hairpin RNA, Cell growth, Homeobox, Transcription factor
References
- Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
- The role of human bromodomains in chromatin biology and gene transcription
- The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
- What Is the Difference Between Triple-Negative and Basal Breast Cancers?
- Methods for the production of first generation adenoviral vectors.
- Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
- Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells.
- Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.
- Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.
- Nucleosome distribution and linker DNA: connecting nuclear function to dynamic chromatin structure
- The structural and mechanical complexity of cell-growth control
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
- Progesterone receptors in human breast cancer. Stoichiometric translocation and nuclear receptor processing.
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
- Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
- Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
- Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
- Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
- HEX expression and localization in normal mammary gland and breast carcinoma
Cited by
Related papers
- PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin
- Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
- Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha.
- Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA‐MB‐231 breast cancer cells through inhibition of NOTCH1 signaling
- microRNA‐133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway
- COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells
- PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation.
- GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A.
- Function of GCN5 in the TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer.
- Knockdown of COUP-TFII enhances cell proliferation, movement, agression, and colony construction in human colorectal cancer HT-29 cells